Search - tctmd.com

Displaying 201 - 220 of 325

Sort: Relevancy | Date

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

Presenter: George D. Dangas, Debabrata Mukherjee, C. Michael Gibson

November 01, 2016

News Conference News TCT 2016

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

Yael L. Maxwell

October 31, 2016

Presentation TCT 2016

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

Presenter: Sorin J. Brener, Jean-François Tanguay, Michela Faggioni

October 31, 2016

Presentation TCT 2016

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

Presenter: Dimitrios Alexopoulos, Laurent Bonello, Ramin Ebrahimi

October 31, 2016

News Conference News TCT 2016

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

Todd Neale

October 31, 2016

Presentation TCT 2016

From ARCTIC to ANTARCTICA: Is the Concept of Tailored Antiplatelet Therapy Finished

Presenter: John A. Bittl, Daniel I. Simon, Eric Van Belle

October 30, 2016

News Conference News TCT 2016

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

Michael O'Riordan

October 30, 2016

News Conference News TCT 2016

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Todd Neale

October 30, 2016

Presentation TCT 2015

Is There a Role for Oral Anticoagulants After PCI?

Presenter: Eric R. Bates, Neal S. Kleiman, C. Michael Gibson

October 15, 2015

Presentation TCT 2015

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda

October 15, 2015

Presentation TCT 2015

Should You Bridge in Stented Patients Needing Surgery?

Presenter: Eric R. Bates, Neal S. Kleiman, David F. Kong

October 15, 2015

News Conference News TCT 2015

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

Nicole Lou

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2015

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

Presenter: Pascal Vranckx, Freek W.A. Verheugt

October 14, 2015

News Conference News TCT 2015

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

Todd Neale

October 14, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

Presentation TCT 2015

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

Presenter: Lisa K. Jennings, Neal S. Kleiman, Rhanderson Cardoso

October 13, 2015

Presentation TCT 2015

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Yaling Han

October 13, 2015

Presentation TCT 2015

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Presenter: Lisa K. Jennings, Neal S. Kleiman, Bo Xu

October 13, 2015

Advertisement

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Antiplatelet Therapy in Patients Who Need Anticoagulation: Current Guidelines, Ongoing Studies

New BRS Studies Show Promise for Second-Generation Devices With Thinner Struts

TCT 66: Effects of Dual Antiplatelet Therapy Cessation Among Patients With Diabetes Mellitus After PCI With DES

TCT 5: Risks and Benefits of Dual Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery: Insights From the ACUITY Trial

‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent

From ARCTIC to ANTARCTICA: Is the Concept of Tailored Antiplatelet Therapy Finished

‘Worrisome’ 3-Year Data From ABSORB II Raise Concerns About First-Generation Bioresorbable Stent

DES With Biodegradable Polymers Stand Up Well Against Durable-Polymer Stents in the Short Term

Is There a Role for Oral Anticoagulants After PCI?

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Should You Bridge in Stented Patients Needing Surgery?

RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Can We Drop Aspirin? Pharmacodynamic Insights on Adding an Oral Anticoagulant to Antiplatelet Therapy With and Without Aspirin

TUXEDO-India Affirms Superiority of EES in Patients With Diabetes

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

TCT 82: Single Versus Dual Antiplatelet Therapy in Transcatheter Aortic Valve Replacement A Meta-analysis of Safety and Efficacy Outcomes

TCT 81: Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable-Polymer Sirolimus-Eluting Stent A Randomized Substudy of the I-LOVE-IT 2 Trial

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions Insights From the I-LOVE-IT 2 Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content